Dudediligence.

Bionano Genomics, Inc

BNGONASDAQ · Laboratory Analytical Instruments
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$6.1MSep ’24$8.2MDec ’24$6.5MMar ’25$6.7MJun ’25$7.4MSep ’25$8.0MDec ’25$6.7MMar ’26$8.2MJun ’26
Net income, by quarter
−$44.2MSep ’24−$20.1MDec ’24−$3.1MMar ’25−$6.9MJun ’25−$8.5MSep ’25−$7.9MDec ’25−$8.3MMar ’26−$7.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$18.0M$27.8M$36.1M$30.8M$28.5M
Gross profit$3.9M$5.9M$9.6M$380,000$13.2M
Operating income−$77.1M−$131.7M−$215.2M−$104.0M−$33.3M
Net income−$72.4M−$132.6M−$232.5M−$112.0M−$26.4M
Operating cash flow−$71.9M−$124.8M−$125.2M−$68.9M−$16.3M
Free cash flownone on file−$127.2M−$126.9M−$69.0M−$16.3M
Cash$24.6M$5.1M$17.9M$9.2M$3.0M
Debt$0.00none on filenone on filenone on filenone on file
Shares outstanding289.6M29.7M762.5K1.9M10.7M